Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of nasopharyngeal carcinoma

Cancer Science

Volumn 107, Issue 9, 2016, Pages 1215-1222

  Li, Li ^a   Gu, Miao ^a   You, Bo ^a   Shi, Si ^a   Shan, Ying ^a   Bao, Lili ^a   You, Yiwen ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Chemoresistance; lncRNA ROR; metastasis; nasopharyngeal carcinoma; proliferation

Indexed keywords

CISPLATIN; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA ROR; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE CONTROL; GENE REPRESSION; GENE TARGETING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; METASTASIS; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84987680082     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12989     Document Type: Article

References (24)

1. Gong Z, Zhang S, Zeng Z et al. LOC401317, a p53-regulated long non-coding RNA, inhibits cell proliferation and induces apoptosis in the nasopharyngeal carcinoma cell line HNE2. PLoS ONE 2014; 9: e110674.
2. Bo H, Gong Z, Zhang W et al. Upregulated long non-coding RNA AFAP1-AS1 expression is associated with progression and poor prognosis of nasopharyngeal carcinoma. Oncotarget 2015; 6: 20404–18.
3. Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet 2015; 7(3): 388–93.
4. Blanchard P, Lee A, Marguet S et al. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 2015; 16: 645–55.
5. Wang Q, Fan H, Liu Y et al. Curcumin enhances the radiosensitivity in nasopharyngeal carcinoma cells involving the reversal of differentially expressed long non-coding RNAs. Int J Oncol 2014; 44: 858–64.
6. Zhao W, Luo J, Jiao S. Comprehensive characterization of cancer subtype associated long non-coding RNAs and their clinical implications. Sci Rep 2014; 4: 6591.
7. Bergmann JH, Spector DL. Long non-coding RNAs: modulators of nuclear structure and function. Curr Opin Cell Biol 2014; 26: 10–8.
8. George J, Patel T. Noncoding RNA as therapeutic targets for hepatocellular carcinoma. Semin Liver Dis 2015; 35: 63–74.
9. Ling H, Vincent K, Pichler M et al. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene 2015; 34: 5003–11.
10. Wang Y, Xu Z, Jiang J et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev Cell 2013; 25: 69–80.
11. Zhang A, Zhou N, Huang J et al. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Res 2013; 23: 340–50.
12. Feng S, Yao J, Chen Y et al. Expression and functional role of reprogramming-related long noncoding RNA (lincRNA-ROR) in glioma. J Mol Neurosci 2015; 56: 623–30.
13. Hou P, Zhao Y, Li Z et al. LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis. Cell Death Dis 2014; 5: e1287.
14. Takahashi K, Yan IK, Haga H, Patel T. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J Cell Sci 2014; 127: 1585–94.
15. Takahashi K, Yan IK, Kogure T, Haga H, Patel T. Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS Open Bio 2014; 4: 458–67.
16. Huang J, Zhou N, Watabe K et al. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death Dis 2014; 5: e1008.
17. Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev 2009; 23: 1494–504.
18. Silva A, Bullock M, Calin G. The clinical relevance of long non-coding RNAs in cancer. Cancers 2015; 7: 2169–82.
19. Nie Y, Liu X, Qu S, Song E, Zou H, Gong C. Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival. Cancer Sci 2013; 104: 458–64.
20. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313–7.
21. Thiery JP. Epithelial–mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740–6.
22. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell 2009; 139: 871–90.
23. Jin C, Yan B, Lu Q, Lin Y, Ma L. The role of MALAT1/miR-1/slug axis on radioresistance in nasopharyngeal carcinoma. Tumour Biol 2016; 37: 4025–33.
24. Sanchez Y, Segura V, Marin-Bejar O et al. Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature. Nat Commun 2014; 5: 5812.